Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

about

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

Item

http://www.wikidata.org/entity/Q38660256

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

@en

type

Item

label

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

@en

prefLabel

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

@en

P1476

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

@en

P2093

Nabil K Thalji

http://www.w3.org/2001/XMLSchema#string

Rodney M Camire

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes

Reversal of target-specific oral anticoagulants

The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models

The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment

Direct oral anticoagulants and venous thromboembolism

Dabigatran versus warfarin in patients with atrial fibrillation

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Idarucizumab for Dabigatran Reversal

Edoxaban versus warfarin in patients with atrial fibrillation

P304

453-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MOH.0000000000000369

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28692575

http://www.w3.org/2001/XMLSchema#string

P921

zymogen

P932

5629015

http://www.w3.org/2001/XMLSchema#string